Abstract
The respiratory tract harbours a variety of microorganisms, collectively called the respiratory microbiota. Over the past few years, alterations in respiratory and gut microbiota composition have been associated with chronic inflammatory diseases of the lungs. How these changes influence disease development and progression is an active field of investigation. Identifying and understanding host-microbiota interactions and factors contributing to these interactions could promote the development of novel therapeutic strategies aimed at restoring host-microbiota homeostasis. In this review, we discuss recent literature on host-microbiota interactions in the respiratory tract, with a specific focus on the influence of endogenous host defence peptides and proteins (HDPs) on the composition of microbiota populations in vivo and explore possible HDPs-related therapeutic approaches targeting microbiota dysbiosis in chronic inflammatory lung diseases.
| Original language | English |
|---|---|
| Article number | 49 |
| Journal | Vaccines |
| Volume | 6 |
| Issue number | 3 |
| DOIs | |
| Publication status | Published - Sept 2018 |
Keywords
- chronic inflammatory lung diseases
- COPD
- Asthma
- cystic fibrosis
- microbiota
- host defence peptides
- host-microbiota interactions
- Microbiota
- Chronic inflammatory lung diseases
- Host-microbiota interactions
- Cystic fibrosis
- Host defence peptides